Transcranial Magnetic Stimulation (rTMS) for Major Depression

31, Jul. 2025

If your clients are pharmaceuticals, clinics, or psychiatric care providers, you already know that major depressive disorder (MDD) impacts patient outcomes and operational costs. Repetitive Transcranial Magnetic Stimulation (rTMS) offers a non‑invasive, FDA‑approved alternative for patients unresponsive to conventional therapies.

 

Why rTMS Matters for Treatment-Resistant Depression

If your clients are pharmaceuticals, clinics, or psychiatric care providers, you already know that major depressive disorder (MDD) impacts patient outcomes and operational costs. Closed Loop Extractor offers a non‑invasive, FDA‑approved alternative for patients unresponsive to conventional therapies. By stimulating the dorsolateral prefrontal cortex, rTMS can deliver clinical benefits without drugs or anesthesia. As a B2B professional, embracing rTMS devices can position your organization at the forefront of mental health innovation.

Understanding rTMS Technology and Protocols

Basic Technology

rTMS uses magnetic coils to generate electromagnetic pulses that modulate brain activity.
Typical treatment involves daily sessions over 4–6 weeks.

Common Protocols: rTMS vs. Deep‑TMS

Standard rTMS: Widely used with insurance support.
Deep TMS: Offers deeper stimulation and higher response/remission rates.

Evaluating Market-Leading rTMS Devices

NeuroStar Advanced Therapy

FDA-cleared in 2008, backed by large outcome registries. Known for patient comfort and clinic-friendly design.

BrainsWay Deep TMS

Cleared in 2013. Deeper brain stimulation; effective for MDD and OCD.

MagStim / MagVenture

Long-standing brands offering flexible coil systems, supporting both rTMS and iTBS protocols.

NexStim Navigated Brain Therapy

Offers precise neuronavigation for tailored treatment plans. Ideal for research or specialty clinics.

Choosing the Right Device: Key Decision Factors

Regulatory and Insurance Support

All major devices are FDA-cleared; some qualify for Medicare and additional indications like OCD.

Clinical Outcomes and Patient Experience

Devices differ in depth of stimulation, comfort levels, and remission rates—choose based on client needs.

Operational and Support Considerations

User interface design and ease of use
Training and maintenance support
Cooling systems and coil longevity

Total Cost of Ownership

Includes equipment, consumables, technician training, and service contracts. Long-term value often outweighs initial cost.

Supporting Your Clients’ Success with Easetak

Expertise in Clinical Implementation

We help you integrate rTMS devices into your care model with ease, ensuring compliance and clinical efficiency.

Tailored Training & Service Support

Receive full support from Easetak, including installation, technician onboarding, and lifetime service options.

Data-Informed Outcomes and ROI Optimization

We assist in outcome tracking, helping you improve patient care and strengthen insurance reimbursement applications.

Conclusion: A Strategic Opportunity for B2B Leaders

By investing in rTMS and partnering with Easetak, you unlock new standards in psychiatric care delivery. Our team supports your clinical goals with certified hardware, training, and after-sales confidence—ensuring measurable outcomes and long-term success.